incubation was done at 37°C and 5% of CO 2 during post-kidney transplantation and mark an evolution to 48 h. Then the cultures supernatants were collected and allograft tolerance. This is the report of our kept at −70°C until tested.
studies.
The supernatants were assayed for IL-2, IL-4, IL-10 and IFN-c production using ELISA kits (Endogen@, Cambridge, MA) according to manufacturer's instruc-
Subjects and methods
tions. Also, serum used as culture medium supplements were assayed for IL-2 and IL-10. The ELISA kits Fifty-six adult cadaver renal transplants recipients, 35 male sensitivities for IL-2, IL-4, IL-10, and IFN-c were and 21 female with an age range of 16-52 years entered the <6 pg/ml, <2 pg/ml, <3 pg/ml, and <2 pg/ml study. All were receiving renal replacement therapy before respectively. transplantation, 53 on haemodialysis and three on CAPD.
The results were analysed by an unpaired Student t The original renal diseases consisted of chronic glomerulotest (serum creatinine and blood CsA), Friedman nephritis/unknown (19 cases), hereditary nephritis/tubuloin-ANOVA for paired samples and Kruskal-Wallis terstitial nephritis (17) , IgA nephropathy (5), polycystic ANOVA for unpaired samples (Statistica@ from renal disease (5), diabetic nephropathy (5), rapidly progressStatsoft). This study was approved by the local Ethics ive glomerulonephritis (2), systemic lupus (1), membranoCommittee, and informed consent was obtained in all proliferative glomerulonephritis (1), Schö nlein-Henoch cases. purpura (1). All were first kidney transplants with the exception of three recipients of a second graft. The transplant
Results
recipients and the donors were typed by microlymphotoxicity tests using well standardized alloantisera.
We examined IL-2 production in 21 samples on day 7 Immunosuppression FNAB culture supernatants and 18 samples for day 30 post-transplantation in group A. The respective Fifty-three patients were treated with triple therapy medians ±SEM were 15±175 pg/ml and (CsA-Aza-Pred ) and the three second transplants received 13.5±176 pg/ml. The high SEM were explained by quadruple therapy, which included rabbit/horse ATG for the three high producers on day 7 cultures and two (one first 7 days post-surgery. The b.i.d. oral CsA dose was of the three day 7) on day 30 cultures; their IL-2 adjusted according to CsA trough levels measured by mono-values were 252, 322, 1600, and 330, 1455 pg/ml clonal TDx@ assay from Abbott. Acute rejection episodes respectively. These four patients had good renal funcwere treated by 3-4 i.v. 500-mg methylprednisolone pulses, tion at both periods, with CsA blood levels within our and by ATG/OKT3 for 7-10 days in steroid-resistant cases therapeutic range (creatinines/CsA: 1.0/250, 3.1/206, and whenever the biopsies were classified grade IIb or greater following Banff criteria.
For group B, we did 16 tests with day 7 FNAB culture supernatants and 22 tests with FNABs done at Acute rejection episodes were confirmed by core renal the beginning of their rejection crisis. The 22 acute biopsy in all but one case where diagnosis was based on rejection episodes occurred during the first 60 days FNAB findings. Also the rejection diagnosis was confirmed by a positive response to antirejection treatment, post-transplantation with the exception of one diabetic with the exception of six irreversible acute rejection case which happened 510 days post-transplantation, cases. Chronic rejection was diagnosed in cases of steady 90 days following steroids withdrawal. The day 7 and slow deterioration of transplant function after exclu-FNABs were done 10±9 days before rejection. IL-2 sion of other causes of graft deterioration and confirmed production at day 7 was 438±387 pg/ml; the values by core renal biopsy findings in six cases. CMV disease measured in culture supernatants of FNAB done at was diagnosed when classical clinical symptoms and the beginning of rejections were 871±387 pg/ml. Six signs appeared with positive cytomegalovirus early of the 22 suffered irreversible rejections, the corresantigenemia.
ponding IL-2 were 1140±318 pg/ml; in supernatants FNAB were done according to the methods described from the other 16 who suffered reversible graft rejecby Haÿry [20] on days 7 and 30 post-transplantation in stable cases, whenever a rejection episode was suspected, tions we measured 441±214 pg/ml. during stable periods of chronic rejection, and on the We performed 10 tests in group C. FNABs were first day of admission in CMV disease. The FNAB were done 615±185 days post-Tx. Eight of the 10 patients done 2 h following morning dose of the immunosuppres-lost their graft function during the year following sive drugs. The samples were aspirated into 6 ml of FNAB. IL-2 was 2.5±92 pg/ml. Two showed 370 and RPMI medium with heparin lithium at 125 Un/ml. After 215 pg/ml, quite interestingly both still retain their red blood cell lysis the crude cell suspensions were kidneys with plasma creatinine oscillating around adjusted to a final concentration of 5×104 cells/200 ml. 3.0 mg/dl. Unfortunately we do not have day 7 FNAB The cultures were done in RPMI medium supplemented from any of these patients.
with penicilin, gentamicin and 1-glutamine, 10% autolThree patients from group D suffered CMV disease ogous serum (derived from blood drawn just before morning dose of the drugs) and 10 U/ml of rIL-2. The during the first 60 days post-transplantation. IL-2 were 844, 485 and 1446 pg/ml; they fully recovered after a therapeutic course of gancyclovir.
The four groups were similarly analysed for IL-10 production. From group A, day 7 FNAB supernatants, we measured 22±32 pg/ml and day 30 supernatants 5±29 pg/ml. For group B, day 7 supernatants contained 2±10 and at the start of rejection 2±12 pg/ml. For the six patients suffering from irreversible rejection, IL-10 was 1±10.9 pg/ml. For group C, IL-10 production was 32±37 pg/ml. The three with CMV disease showed 112, 115 and 160 pg/ml of IL-10.
We further analysed the results from group A and B with exclusion of groups C and D. IL-2 Á250 pg/ml Fig. 2 . Correlation between day 7 and rejection day for IL-2, r= was assumed as cut-off value for acute rejection dia-0.53, P=0.031. gnosis. The sensitivity was 22/22, 100%, specificity was 34/34+5, 87.2%. The positive predictive value was For IL-10 they were 0.04, −0.31, 0.10 and −0.04, groups A and B respectively. For group C the correlations between IL-2, IL-10 vs CsA were −0.1 and samples for IFN-c prevented any meaningful statistical −0.22 respectively. In addition there was no significant analysis. Groups C and D were not studied for IFN-c. correlation between serum creatinine versus either IL-2 Serum used as culture medium supplements were or IL-10 for group A, B, and C. For group B we found analysed for IL-2 and IL-10. We did not find IL-2 in a positive correlation between day 7 vs rejection day any serum sample. Concerning IL-10, group A day 7 for IL-2, 0.53, P=0.031 (Figure 2 ). In Table 1 we and day 30, median±SEM were 6.0±6.3 pg/ml and present plasma creatinine and blood CsA levels of the 6.5±14.1 pg/ml respectively; in group B day 7 and four groups. In Table 2 the analysis of the results by rejection day we measured 8.0±18.4 pg/ml and ANOVA are shown.
7.8±14.7 pg/ml, in group C, 5.0±6.4 pg/ml and the FNAB culture supernatants from groups A, B, C three patients from group D, 65, 82 and 77 pg/ml. and D did not show any trace of IL-4.
IFN-c was only found in two patients from group A, one of the two producing IFN-c both from day 7 Discussion FNAB and day 30 FNAB. Five culture supernatants from group B contained small amounts of IFN-c (3, 13, 22, 45, 55 pg/ml ). This small number of positive Several conclusions can be drawn from our results.
First, our FNAB cultures have the ability to produce several cytokines, contrary the findings by Yard et al.
[25] who showed that unstimulated graft-infiltrating cells cultures were unable to synthesize any cytokine. We supplemented our cultures with 10 U/ml of rIL-2 only, and this amount is less than half the dose used for propagation of activated T cells from allograft biopsies [26 ] . We decided to use autologous serum as culture medium supplement as this might reflect the in vivo milieu more closely while at the same time not eliminating the possible interference of CsA levels. However, as can be seen by correlation analysis between supernatant IL-2 and CsA, cyclosporin blood values did not have a major influence in stable patients FNAB culture IL-2, and quite unexpectedly we observed a positive correlation within rejection group. The absence of IL-2 and the amount of IL-10 measured in serum samples could not explain the different cyto-cytokine in 'pure humoral' rejection as we have only one such case studied. This patient, a 17-year-old male kine production patterns by FNAB cultures. Also, different to conditions of Yard et al. [25] , our system lost his graft following a Banff grade III rejection, presenting disseminated arteries thrombosis with mild is a coculture, the main cells involved are donor parenchymal renal cells with host mononuclear cells to moderate interstitial mononuclear infiltration, and his IL-2/IL-10 values at start of rejection were and this may account for the differences in our results. Actually one might consider that we are performing a 1018/41.2 pg/ml respectively. Actually this IL-10 value was the second highest measured among group B, and mixed lymphocyte culture variant, but in our test donor alloantigen is provided by either renal cells or the highest was seen in a female recipient suffering a severe Banff grade IIb rejection successfully treated more probably, by recipient antigen-presenting cells infiltrating the kidney graft. Alternatively, procedures with a course of horse ATG. However, her IL-2 reached up to 993 pg/ml while her IL-10 was 89 pg/ml. for graft-infiltrating lymphocytes isolation from core renal biopsies could interfere with cells capacity to We speculate that IL-10 might be synthesized by monocyte-macrophage population present in our coculture. synthesize cytokines. Some doubts could be raised by a possible FNAB sample contamination by blood. Interestingly, there is a significantly increased presence of CD14+ cells in our FNAB taken from steroidHowever, we looked at the samples under lightmicroscopy following a modified Romanowski stain, resistant acute rejection cases [24] .
FNAB done on day 7 post-transplantation in and only those samples that did not show significant blood contamination were subjected to culture (this group B, 10±9 days before the start of the rejection crisis, showed a significantly higher IL-2 production was assessed according Haÿry classification [20] ). Furthermore we have run a study by flow cytometry than their counterparts from group A. This important finding suggests that immunological activation is of the FNAB samples together with the corresponding peripheral blood and this has demonstrated the absence already on course at day 7 and ultimately would lead to acute rejection crisis. The correlation between day 7 of significant blood contamination, as the analysed lymphocyte subsets presented several differences when IL-2 and rejection IL-2 was 0.59, P=0.014 ( Figure 2) .
CsA blood levels were not responsible for these results we compared FNAB to peripheral blood lymphocytes [27] .
as there were no significantly differences comparing day 7 CsA levels from group A with day 7 in group B IL-2 and IL-10 analysis of FNAB cultures were very rewarding as a distinct pattern emerged from stable ( Table 1 ). Only one of 16 patients deviated from this behaviour, the other 15 had IL-2 from 270 up to and rejecting patients. Group A (stable), showed a Th0/Th2 cytokine pattern, with a few exceptions (3/21) 1700 pg/ml. The outsider produced just a small amount of IL-10 with no IL-2 and he was the first patient to from day 7 samples. This group has enjoyed a rejectionfree first year post-transplantation, including the three enter this study. We cannot exclude that a preservation problem affected his supernatant. The day 7 IL-2 high-IL-2 producers. We suspect that these three patients are cases of intragraft activation without clin-synthesis may act as a warning of the risk of an impending rejection crisis, and at the same time potenical consequences [28] , a poorly understood phenomenon that has been previously reported. The blood tially point to a CsA failure as an IL-2 synthesis inhibitor. One may then preempt this situation by CsA levels measured on these three patients were within the therapeutic range.
increasing the CsA dose, specially in those with low to normal blood levels, or to add a new immunosuppresGroup B displayed a predominant Th1 cytokine pattern. IL-2 values ranged from 370 pg/ml up to sive drug.
Chronic rejection patients showed Th2 cytokine pat-1640 pg/ml. Interestingly, irreversible acute rejection episodes were accompanied by significantly higher IL-2 tern. This is in agreement with a recent report of intragraft cytokine mRNA expression [30] where the values than in reversible acute rejection episodes. The almost complete IL-10 inhibition in rejection cases authors did not observe IL-2 upregulation, but rather IL-10 from core renal biopsies. We are quite confident compared to values measured in stable cases points to its important role in human renal transplantation and of the chronic rejection diagnosis of the four cases without renal biopsies. All of them lost their grafts. goes against a predominant part for IL-10 in severe graft rejection, as others have suggested [29] . However, Their original renal diseases were vesicoureteral reflux
[2], IgA nephritis and chronic glomerulonephritis. One we cannot exclude that IL-10 might be the predominant could argue that IL-10 was produced by monocyte-supernatants analysis showed a Th0/Th2 cytokine pattern in stable patients, predominant Th1 during macrophage but even so, one would expect that T lymphocytes exposed to IL-10 in the absence of IL-2 acute rejection, Th2 during chronic rejection and Th0 at start of CMV disease not followed by acute would deviate to a Th2 pattern, probably.
The similar IL-10 values measured in stable and rejection. More importantly, IL-2 produced by FNAB done on day 7 post-transplantation reliably predicted chronic rejecting patients highlights the extreme complexity of this cytokine. IL-10 is produced by T and B an ensuing rejection episode and IL-2 on rejection day signalled irreversible rejection. In case our results lymphocytes and antigen-presenting cells [31] and is endowed with both stimulant and depressing effects on are confirmed in a larger group of patients, this test could prove a very useful method for immunological the immune cascade. IL-10 downregulates B7 [32] bers in our samples [24] . In summary, renal transplant FNAB culture
